Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30.
Published June 2, 2021 · Recall initiated: April 29, 2021
Summary
FDA records drug Class III recall D-0392-2021, published June 2, 2021 and initiated April 29, 2021. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: 34296 bottles; Lot: Batch No. 20122548, Exp Date: Aug. 2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablet/Capsule
What to do
Voluntary: Firm initiated · Letter
Get an email if OLMESARTAN MEDOXOMIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- OLMESARTAN MEDOXOMIL
- Manufacturer
- Ascend Laboratories LLC
- Distributor
- Nationwide
- UPC
- 0367877445304
- Lot
- Batch No. 20122548, Exp Date: Aug. 2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADaytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDCJune 2, 2021
- FDADaytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches (NDCJune 2, 2021
- FDA11G DIRECT SINGLE - ACCESS, CODE INTVMN-DSBAKMay 26, 2021
- FDA11G DIRECT SINGLE - DELIVERY (4 FILLERS-4 SYRINGES), CODE INTVMN-SCDKMay 26, 2021
- FDABPB medica CEMIX, PRODUCT NUMBER KVTMIXN, Vertebroplasty-Kyphoplasty cement mixing systemMay 26, 2021
- FDAOlmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd.,February 12, 2020
Questions about this recall
Was Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30. recalled?
Yes. FDA published recall D-0392-2021 on June 2, 2021. Reported hazard: Presence of Foreign Tablet/Capsule
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: OLMESARTAN MEDOXOMIL. UPC: 0367877445304.